New Hope For People With Dysglycemia and Cardiovascular Disease Manifestations

This publication has 15 references indexed in Scilit:

• Clinical Implications of Cardiovascular Outcome Trials in Type 2 Diabetes: From DCCT to EMPA-REG
  Clinical Therapeutics, 2016
• Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study
  PLOS ONE, 2015
• Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: Long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort
  Diabetes and Vascular Disease Research, 2014
• Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
  The Lancet Diabetes & Endocrinology, 2014
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
  European Heart Journal, 2013
• Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
  Circulation, 2009
• Insulin resistance and atherosclerosis
  Journal of Clinical Investigation, 2006
• Thiazolidinediones
  New England Journal of Medicine, 2004
• Diabetology for cardiologists
  European Heart Journal Supplements, 2003
• Role of Insulin Resistance in Human Disease
  Diabetes, 1988